Zobrazeno 1 - 10
of 28
pro vyhledávání: '"LC Batista"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S248- (2021)
Introduction: The emerging of chimeric antigen receptor (CAR) T cell therapy has shown promising results leading to the FDA approval of five CAR T cell products by now. Anti CD19 CAR T cells have shown >80% complete remission rates in acute B cell le
Externí odkaz:
https://doaj.org/article/b8d4cad85859438cbed65b9f6f3f73cf
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S258-S259 (2021)
Introduction: Chimeric antigen receptor (CAR)-T cell therapy has a remarkable clinical success. However, its autologous nature reduces accessibility to the therapy. Thus, one of the next frontiers in the field is to develop an allogeneic, ‘off-the-
Externí odkaz:
https://doaj.org/article/ba0f6496d3744f24923aa9254d7ad0e9
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S267- (2021)
Introdução: O tratamento com linfócitos T expressando receptores quiméricos de antígeno (CAR) ou receptores de células T (TCR) artificiais tem resultado em taxas de remissão impressionantes para algumas neoplasias hematológicas. Porém, a efi
Externí odkaz:
https://doaj.org/article/7ea4b15d7e784865a8a7f03fa69e4e4a
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S644
Publikováno v:
Cytotherapy. 23:13-14
Background Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells have shown remarkable remission rates in acute B cell leukemias. It has been reported that anti-CD19 CAR-T cells sustain complete remission of leukemia even when their numbers in
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S248-(2021)
Introduction: The emerging of chimeric antigen receptor (CAR) T cell therapy has shown promising results leading to the FDA approval of five CAR T cell products by now. Anti CD19 CAR T cells have shown >80% complete remission rates in acute B cell le
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 421-422 (2020)
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 416-417 (2020)
Autor:
FA Castro, Scg Lima, H Brand, Dimas Tadeu Covas, Dmc Fantacini, M. R. Coelho, LC Batista, Leb Souza
Publikováno v:
Cytotherapy. 23:10
Background Despite its remarkable clinical success, the autologous nature of chimeric antigen receptor (CAR)-T cell therapy restricts the access of patients to this treatment. Thus, one of the next frontiers in the field is to develop an allogeneic,
The companies are increasingly focusing on their clients, in order to achieve their loyalty. Aiming at this goal, are being employed some tools that demonstrate the ability of the firms to keep up with the demands of the market, increasingly ri g o r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2024f2dc69a8668c3dbb2d8670f14a0